Literature DB >> 15829278

Intestinal epithelial TOLLerance versus inTOLLerance of commensals.

Elke Cario1, Daniel K Podolsky.   

Abstract

This brief review summarizes the current understanding of Toll-like receptor (TLRs) mediated intestinal epithelial mechanisms of commensal tolerance versus intolerance and provides an update on the downstream negative control of signaling responses through decreased surface expression, interregulation with NOD2, overexpression of Tollip, various inhibitors of NF-kappaB as well as soluble tolerizing mediators present in lumen and serum which all may maintain or--when dysregulated--impair mucosal homeostasis in health or disease, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15829278     DOI: 10.1016/j.molimm.2004.12.002

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  34 in total

Review 1.  Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2.

Authors:  E Cario
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

Review 2.  The "polarizing-tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis.

Authors:  Jongdae Lee; Jose M Gonzales-Navajas; Eyal Raz
Journal:  Semin Immunopathol       Date:  2007-11-20       Impact factor: 9.623

3.  Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis.

Authors:  Fabio Alessandro Facchini; Davide Di Fusco; Simona Barresi; Andrea Luraghi; Alberto Minotti; Francesca Granucci; Giovanni Monteleone; Francesco Peri; Ivan Monteleone
Journal:  Eur J Clin Pharmacol       Date:  2020-01-25       Impact factor: 2.953

4.  Role of gut microbiota in a zebrafish model with chemically induced enterocolitis involving toll-like receptor signaling pathways.

Authors:  Qi He; Lin Wang; Fan Wang; Qiurong Li
Journal:  Zebrafish       Date:  2014-04-23       Impact factor: 1.985

5.  Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

Authors:  B Szebeni; G Veres; A Dezsõfi; K Rusai; A Vannay; M Mraz; E Majorova; A Arató
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

Review 6.  Toll-like receptors in inflammatory bowel diseases: a decade later.

Authors:  Elke Cario
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

7.  Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes.

Authors:  Jin Wang; Yannan Ouyang; Yigit Guner; Henri R Ford; Anatoly V Grishin
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

8.  Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota.

Authors:  Jennifer M Bates; Janie Akerlund; Erika Mittge; Karen Guillemin
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

Review 9.  Human Milk Components Modulate Toll-Like Receptor-Mediated Inflammation.

Authors:  YingYing He; Nathan T Lawlor; David S Newburg
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

10.  Maintenance treatment with infliximab for the management of Crohn's disease in adults.

Authors:  Renato Caviglia; Ivo Boskoski; Michele Cicala
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.